2SHEP Collaborative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension:final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA, 1991,256:3255-3264.
3Staessen JA,Fagard R,Thijs L, et al. for the Systolic Hypertension in Europe(Syst-Eur) Trail Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet, 1997,350:757-764.
4Liu L,Wang JG,Gong LS ,et al. for the Syst-China Collaborative Group.Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens, 1998,16:1823-1829.
5Kjeldsen SE, Dahlof B, Devereux RB,et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction(LIFE) substudy. JAMA ,2002,288:1491-1498.
6Scottish Intercollegiate Guidelines Network. Hypertension in older people. A National Clinical Guideline,2001 ,January.
7Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drugs trails. J Hypertens,2002,20:1461-1464.
8Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, and treatment of high blood pressure:The JNC 7 report. JAMA,2003,289:2560-2572.
9Voko Z, Bots ML, Hofman A, et al. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension, 1999,34:1181-1185.
10Somes GW,Pahor M,Shorr RI,et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch intern Med, 1999,34:1181-1185.
